These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8666774)

  • 1. CD95 (Fas/Apo-1)-induced apoptosis results in loss of glucose transporter function.
    Berridge MV; Tan AS; McCoy KD; Kansara M; Rudert F
    J Immunol; 1996 Jun; 156(11):4092-9. PubMed ID: 8666774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils.
    Ahmed N; Berridge MV
    Pharmacol Toxicol; 2000 Mar; 86(3):114-21. PubMed ID: 10752668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.
    Holmström TH; Schmitz I; Söderström TS; Poukkula M; Johnson VL; Chow SC; Krammer PH; Eriksson JE
    EMBO J; 2000 Oct; 19(20):5418-28. PubMed ID: 11032809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular taurine release triggered by stimulation of the Fas(CD95) receptor in Jurkat lymphocytes.
    Lang F; Madlung J; Uhlemann AC; Risler T; Gulbins E
    Pflugers Arch; 1998 Aug; 436(3):377-83. PubMed ID: 9644219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.
    Jenkins M; Keir M; McCune JM
    J Immunol; 1999 Aug; 163(3):1195-204. PubMed ID: 10415014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis of human T-cells: induction by glucocorticoids or surface receptor ligation in vitro and ex vivo.
    Kirsch AH; Mahmood AA; Endres J; Bohra L; Bonish B; Weber K; Fox DA
    J Biol Regul Homeost Agents; 1999; 13(2):80-9. PubMed ID: 10503730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway.
    Parlato S; Giammarioli AM; Logozzi M; Lozupone F; Matarrese P; Luciani F; Falchi M; Malorni W; Fais S
    EMBO J; 2000 Oct; 19(19):5123-34. PubMed ID: 11013215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T lymphocytes.
    Weis M; Schlegel J; Kass GE; Holmström TH; Peters I; Eriksson J; Orrenius S; Chow SC
    Exp Cell Res; 1995 Aug; 219(2):699-708. PubMed ID: 7543858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
    Villunger A; Egle A; Kos M; Hartmann BL; Geley S; Kofler R; Greil R
    Cancer Res; 1997 Aug; 57(16):3331-4. PubMed ID: 9269989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against CD95-mediated apoptosis by inorganic mercury in Jurkat T cells.
    Whitekus MJ; Santini RP; Rosenspire AJ; McCabe MJ
    J Immunol; 1999 Jun; 162(12):7162-70. PubMed ID: 10358162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus.
    Scheller C; Knöferle J; Ullrich A; Prottengeier J; Racek T; Sopper S; Jassoy C; Rethwilm A; Koutsilieri E
    J Cell Biochem; 2006 Apr; 97(6):1350-61. PubMed ID: 16365881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes.
    Hornung F; Zheng L; Lenardo MJ
    J Immunol; 1997 Oct; 159(8):3816-22. PubMed ID: 9378969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
    Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
    J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1).
    Bröker BM; Kraft MS; Klauenberg U; Le Deist F; de Villartay JP; Fleckenstein B; Fleischer B; Meinl E
    Eur J Immunol; 1997 Nov; 27(11):2774-80. PubMed ID: 9394798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications.
    Gajate C; Mollinedo F
    J Leukoc Biol; 2015 Nov; 98(5):739-59. PubMed ID: 26246489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C regulates Fas (CD95/APO-1) expression.
    Wang R; Zhang L; Yin D; Mufson RA; Shi Y
    J Immunol; 1998 Sep; 161(5):2201-7. PubMed ID: 9725212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A noncomitogenic CD2R monoclonal antibody induces apoptosis of activated T cells by a CD95/CD95-L-dependent pathway.
    Fournel S; Robinet E; Bonnefoy-Bérard N; Assossou O; Flacher M; Waldmann H; Bismuth G; Revillard JP
    J Immunol; 1998 May; 160(9):4313-21. PubMed ID: 9574534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.